volunteers who were diagnosed with allergic rhinitis by medical docter Prabchompoothaweeb, allergic rhinitis
Conditions
Interventions
Prabchompoothaweeb 300 mg orally per day for 6 weeks,Loratadine 10 mg orally per day for 6 weeks
Active Comparator Drug,Active Comparator Drug
Prabchompoothaweeb extract,Loratadine
Sponsors
Thailand Science Research and Innovation Fund (TSRI Fund)
Eligibility
Sex/Gender
All
Age
20 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1. Age 20-60 year old 2. Have a history of allergic rhinitis 3. Diagnosed with allergic rhinitis by medical doctor 4. Do not have serious respiratory disease such as tuberculosis 5. No history of congenital disease, peptic ulcer and Gerd. 6. Have Hematology, liver and kidneys functions in normal range. 7. Volunteers can read and write Thai language.
Exclusion criteria
Exclusion criteria: 1. Allergic reactions to Prabchompoothaweeb medications. 2. Allergic reactions or get severe side effects from Loratadine 3. Have symptoms of severe Urticaria and Anaphylaxis 4. Immunocompromised volunteers or are chronic patients with serious diseases such as AIDS. 5. Take medicines for congenital disease. 6. Pregnant or lactating 7. Participant in another study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| releive of allergic symptom 6 week TNSS score, ARM score | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life 6 week RCQ36 | — |
Countries
Thailand
Contacts
Public ContactArunporn Itharat
Thammasat University
Outcome results
None listed